CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / Common Stock
Shares outstanding
123,180,519
Total 13F shares
23,623,262
Share change
+1,338,070
Total reported value
$78,388,100
Put/Call ratio
11%
Price per share
$3.32
Number of holders
51
Value change
+$8,077,982
Number of buys
29
Number of sells
23

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q3 2014

As of 30 Sep 2014, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,623,262 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, FEDERATED INVESTORS INC /PA/, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Visium Asset Management, LP, Broadfin Capital, LLC, MORGAN STANLEY, Opaleye Management Inc., Catalyst Capital Advisors LLC, and SPHERA FUNDS MANAGEMENT LTD.. This page lists 51 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2014 vs Q2 2014 Across Filers

Q2 2014 holders
46
Q3 2014 holders
51
Holder diff
5
Investor Q2 2014 Shares Q3 2014 Shares Share Diff Share Chg % Q2 2014 Value $ Q3 2014 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.